ESTABLISHING EQUIVALENCE BY SHOWING THAT A SPECIFIED PERCENTAGE OF THE EFFECT OF THE ACTIVE CONTROL OVER PLACEBO IS MAINTAINED
From MaRDI portal
Publication:4512645
DOI10.1081/BIP-100101201zbMath0962.62102OpenAlexW1975546893WikidataQ41704428 ScholiaQ41704428MaRDI QIDQ4512645
Publication date: 6 February 2001
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1081/bip-100101201
Related Items (4)
A group sequential type design for three-arm non-inferiority trials with binary endpoints ⋮ Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial ⋮ On Non-inferiority Analysis Based On Delta-method Confidence Intervals ⋮ A Test of Non Null Hypothesis for Linear Trends in Proportions
This page was built for publication: ESTABLISHING EQUIVALENCE BY SHOWING THAT A SPECIFIED PERCENTAGE OF THE EFFECT OF THE ACTIVE CONTROL OVER PLACEBO IS MAINTAINED